drugset / Trial / NCT05565079

Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative

NCT05565079

Phase 4 Completed 24 enrolled University of Louisville
RandomizedParallel-groupTriple-blindTreatment

Summary

24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thickness.

Timeline

Start
2022-10-06
Primary completion
2024-10-07
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Emdogain Other / unclassified
Background AlloDerm Other / unclassified

Indications